<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6603191</article-id><article-id pub-id-type="publisher-id">45960</article-id><article-id pub-id-type="doi">10.1038/s41598-019-45960-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Intensity Modulated Radiation Fields Induce Protective Effects and Reduce Importance of Dose-Rate Effects</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Matsuya</surname><given-names>Yusuke</given-names></name><address><email>y-matsuya1028@frontier.hokudai.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5980-6728</contrib-id><name><surname>McMahon</surname><given-names>Stephen J.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2467-9156</contrib-id><name><surname>Ghita</surname><given-names>Mihaela</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Yoshii</surname><given-names>Yuji</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Sato</surname><given-names>Tatsuhiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Date</surname><given-names>Hiroyuki</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6134-7946</contrib-id><name><surname>Prise</surname><given-names>Kevin M.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label>Japan Atomic Energy Agency (JAEA), Nuclear Science and Engineering Center, Research Group for Radiation Transport Analysis, 2-4 Shirakata, Tokai, 319-1195 Ibaraki Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2173 7691</institution-id><institution-id institution-id-type="GRID">grid.39158.36</institution-id><institution>Graduate School of Health Sciences, </institution><institution>Hokkaido University, </institution></institution-wrap>Kita-12 Nishi-5, Kita-ku, Sapporo, 060-0812 Hokkaido Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0374 7521</institution-id><institution-id institution-id-type="GRID">grid.4777.3</institution-id><institution>Centre for Cancer Research and Cell Biology, </institution><institution>Queen&#x02019;s University Belfast, </institution></institution-wrap>97 Lisburn Road, BT7 9AE Belfast, UK </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0691 0855</institution-id><institution-id institution-id-type="GRID">grid.263171.0</institution-id><institution>Biological Research, Education and Instrumentation Center, </institution><institution>Sapporo Medical University, </institution></institution-wrap>Minami-1 Nishi-17, Chuo-ku, Sapporo, 060-8556 Hokkaido Japan </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2173 7691</institution-id><institution-id institution-id-type="GRID">grid.39158.36</institution-id><institution>Faculty of Health Sciences, </institution><institution>Hokkaido University, </institution></institution-wrap>Kita-12 Nishi-5, Kita-ku, Sapporo, 060-0812 Hokkaido Japan </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>1</day><month>7</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>9</volume><elocation-id>9483</elocation-id><history><date date-type="received"><day>13</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">In advanced radiotherapy, intensity modulated radiation fields and complex dose-delivery are utilized to prescribe higher doses to tumours. Here, we investigated the impact of modulated radiation fields on radio-sensitivity and cell recovery during dose delivery. We generated experimental survival data after single-dose, split-dose and fractionated irradiation in normal human skin fibroblast cells (AGO1522) and human prostate cancer cells (DU145). The dose was delivered to either 50% of the area of a T25 flask containing the cells (half-field) or 100% of the flask (uniform-field). We also modelled the impact of dose-rate effects and intercellular signalling on cell-killing. Applying the model to the survival data, it is found that (i) in-field cell survival under half-field exposure is higher than uniform-field exposure for the same delivered dose; (ii) the importance of sub-lethal damage repair (SLDR) in AGO1522 cells is reduced under half-field exposure; (iii) the yield of initial DNA lesions measured with half-field exposure is smaller than that with uniform-field exposure. These results suggest that increased cell survival under half-field exposure is predominantly attributed not to rescue effects (increased SLDR) but protective effects (reduced induction of initial DNA lesions). In support of these protective effects, the reduced DNA damage leads to modulation of cell-cycle dynamics, i.e., less G<sub>1</sub> arrest 6&#x02009;h after irradiation. These findings provide a new understanding of the impact of dose-rate effects and protective effects measured after modulated field irradiation.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Apoptosis</kwd><kwd>Applied mathematics</kwd><kwd>Computational science</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Recent radiotherapy has evolved to use modulated radiation intensity and complex dose-delivery techniques such as intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). These approaches provide a high level of dose conformity to the target tumour volume, preserving organs at risk<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. Dose-rates used for external irradiation in radiotherapy (i.e., about 4&#x02009;Gy/min)<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> are much higher than brachytherapy (i.e., about 12&#x02009;Gy/h or 50&#x02009;cGy/h)<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>, however some modalities such as IMRT, MRI-linacs<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> and Cyberknife<sup><xref ref-type="bibr" rid="CR6">6</xref></sup> need relatively long times to deliver the prescribed dose compared to previously used methods such as conformal therapy (3D-CRT)<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Recent clinical dose-rate studies indicate that cell recovery during irradiation (hereafter called sub-lethal damage repair: SLDR<sup><xref ref-type="bibr" rid="CR8">8</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>) cannot be ignored, even for the case of high-dose-rate radiation therapy<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.</p><p id="Par3">Radiation-hit cells and non-hit cells co-exist during intensity modulated field exposures. Regarding this, <italic>in vitro</italic> experimental configurations containing in-field and out-of-field cells have been established<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>, and their biological effects have been previously studied<sup><xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR14">14</xref></sup>. Specifically, it was shown that using a 50% in-field and 50% out-of-field (half-field) irradiation as a simple model of modulated-field treatment, intercellular communication (IC) from cells in-field to cells out-of-field reduces survival of out-of-field cells<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR15">15</xref></sup>. This enhancement of cell death attributed to IC is referred to non-targeted effects or radiation-induced bystander effects<sup><xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref></sup>. In contrast, there are also several reports about signal-induced radio-resistance<sup><xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref></sup>, which can sometimes be observed in cells in-field under half-field irradiation in comparison with a uniform field exposure<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup>. This radio-resistance is assumed to be attributed to the increase of DNA repair efficiency by rescue effects<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. However, McGarry <italic>et al</italic>. showed that there was no statistically significant cell recovery of AGO-1522b cells during the delivery of a 9-field IMRT delivery in comparison to acute irradiation at 4&#x02009;Gy/min<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. This response contradicts what is expected from reported rescue effects. Thus, we are interested in elucidating the underlying mechanisms of modulated beam exposures via a comprehensive analysis of <italic>in vitro</italic> experiments combined with modelling approaches.</p><p id="Par4">From the standpoint of modelling studies, the linear-quadratic (LQ) model<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup> has been generally accepted in the fields of radiation therapy and radiation biology<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref></sup>. However, more detailed models are needed to define mechanisms by considering effects due to microdosimetry and cell recovery by virtue of SLDR<sup><xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref></sup>. For example, the time factor in the microdosimetric-kinetic (MK) model<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> represents the sub-lethal damage repair (SLDR) rate which can be deduced from a split-dose cell recovery curve<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. Amongst many models developed by several researchers<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR33">33</xref></sup>, the &#x0201c;<italic>integrated microdosimetric-kinetic</italic> (<italic>IMK</italic>) <italic>model</italic>&#x0201d;<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup> is suitable for analysing impact of IC for intensity-modulated fields and SLDR during irradiation. From <italic>in vitro</italic> experiments for modulated fields, we have also used this modelling approach to interpret the mechanisms of the radio-resistance.</p><p id="Par5">Here, we focused on radio-sensitivity and dose-rate effects following exposure to intensity modulated fields. Using a simple geometry where 50% of the area of the cell culture flask is exposed, the in-field cell survival and out-of-field cell survival were quantified. Through this comprehensive study with <italic>in vitro</italic> experiments and modelling, we show the reduced importance of SLDR and presence of protective effects in irradiated healthy cells in modulated fields.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and Methods</title><sec id="Sec3"><title>Cell culture</title><p id="Par6">Experiments were performed using two human cell lines, the human skin fibroblast cell line, AGO1522, as a normal cell model, and the human prostate cancer cell line, DU145, as a tumour cell model. AGO1552 and DU145 cells were obtained from the Coriell Institute for Medical Research (Camden, NJ, USA) and Cancer Research UK, respectively. AGO1522 cells were grown in Eagle&#x02019;s minimum essential medium supplemented with 20% fetal bovine serum (FBS) and 1% penicillin/streptomycin (p/s). DU145 cells were grown in RPMI-1640 with L-glutamine supplemented with 10% FBS, 1% p/s. These cell lines were maintained at 37&#x02009;&#x000b0;C in a humidified atmosphere of 5% CO<sub>2</sub>.</p></sec><sec id="Sec4"><title>Irradiation setup and planning</title><p id="Par7">All irradiations in this study have been performed using a 225 kVp X-ray (Precision x-Ray) source at dose rates of 0.59&#x02009;Gy/min or 0.18&#x02009;Gy/min. The dose was delivered to either 50% of the area of T25 flask containing cells or 100% of the flask as previously reported<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>.</p><p id="Par8">For the exposure of 50% cells in a culture flask, a T25 flask (Nunclon surface NUNC) was placed at the center of radiation beam, and half of the flask was shielded using a lead block (13.6&#x02009;&#x000d7;&#x02009;10.4&#x02009;&#x000d7;&#x02009;2.1&#x02009;cm<sup>3</sup> lead blocks MCP60-Mining &#x00026; Chemical Products Ltd.). At the bottom of each flask, RTQA Gafchromic&#x000ae; film (Vertec Scientific Ltd.) was attached to monitor the dose boundaries. Schematic representations of the irradiation geometry and dose profile are illustrated in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A,B</xref>. The dose profile was also checked by using the Monte Carlo simulation code, Particle and Heavy Ion Transport Code System (PHITS ver. 3.02)<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.<fig id="Fig1"><label>Figure 1</label><caption><p>Study design for <italic>in vitro</italic> experiments with irradiation, Monte Carlo simulation and assumptions of the mathematical model: (<bold>A</bold>) illustrates the geometry of half-field irradiation, (<bold>B</bold>) is the dose profile compared between Gafchromic film and Monte Carlo simulation by PHITS ver. 3.02<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>, (<bold>C</bold>) is the temporal characteristics of dose delivered to cultured cells at different dose-rates and (<bold>D</bold>) represents the assumptions for modelling the signal range under half-field exposure, where <italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5 (gray area) and <italic>A</italic><sub>OF</sub>&#x02009;=&#x02009;0.5 (light gray area) are the fractions of in-field and out-of-field area in the modulated field, respectively. It is assumed that intercellular signals can cover the entire region of the flask for both cases of half and uniform-fields, based on previous experimental data<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>.</p></caption><graphic xlink:href="41598_2019_45960_Fig1_HTML" id="d29e547"/></fig></p><p id="Par9">The cells were exposed by means of either a single-dose irradiation, a split-dose irradiation to evaluate sub-lethal damage repair (SLDR) or one of four different dose regimen for the dose-rate study. For split-dose experiments, a dose of 4&#x02009;Gy split into two equal fractions was used with various inter-fraction times (0, 0.25, 0.5, 1, 2, 4, 24 and 48&#x02009;h). We also compared four different dose plans equivalent to 0.59, 0.2, 0.1, 0.05&#x02009;Gy/min, on average, for a total absorbed dose of 4&#x02009;Gy. A temporal cell&#x02019;s-eye view of dose-delivery is described in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>.</p></sec><sec id="Sec5"><title>Clonogenic survival assay</title><p id="Par10">Cell survival was measured by means of a clonogenic assay as previously described<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Cells were plated and allowed to adhere overnight before irradiation. All exposures were performed at room temperature. The cells, after irradiation, were incubated for 10&#x02013;14 days before staining with 0.5% crystal violet in 70% methanol.</p></sec><sec id="Sec6"><title>Flow cytometric analysis of cell-cycle distribution</title><p id="Par11">To understand changes in radio-sensitivity under half-field exposure, we also measured cell-cycle dynamics by using a co-culture system. Co-cultured cells were plated sub-confluently on glass slides and allowed to adhere overnight as previously reported<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>.</p><p id="Par12">Less than 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> cells at 0, 6, 24, 72&#x02009;h after irradiation were fixed with 70% ethanol (in 0.5&#x02009;mL of PBS and 4.5&#x02009;mL of 70% ethanol) and kept at 4&#x02009;&#x000b0;C for at least 2&#x02009;h. After centrifugation, the cells were suspended in 1&#x02009;mL PBS. After centrifugation for 10&#x02009;min at 300&#x02009;g at 4&#x02009;&#x000b0;C, ethanol was thoroughly removed (or decanted). Cells were then treated with 0.5&#x02009;mL of PI staining solution (20&#x02009;&#x003bc;g/mL PI, 20&#x02009;&#x003bc;g/mL DNase-free RNase A, 0.1%v/v TritonX100) and kept in the dark at 37&#x02009;&#x000b0;C for 15&#x02009;min.</p></sec><sec id="Sec7"><title>Model analysis and overview</title><p id="Par13">A mathematical model was used to analyse the measured experimental data<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. Cell survival considering DNA damage along the radiation track (so called DNA targeted effects: DNA-TEs) and Non-Targeted Effects (NTEs) was previously modelled using the IMK model<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. In this study, the IMK model was modified so as to include the modulated radiation field shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>. In this model, reparable lesions (potentially lethal lesion: PLL) are assumed to be DNA lesions with cell toxicity, which may transform into non-reparable lesions (lethal lesions: LLs) or be completely repaired<sup><xref ref-type="bibr" rid="CR28">28</xref></sup>. Solving the kinetic equation for DNA lesions, cell surviving fraction can be calculated for both half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) cases, where <italic>A</italic><sub>IF</sub> is the fraction of in-field area used in the experimental design (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>).</p></sec><sec id="Sec8"><title>Modelling of targeted effects (TEs)</title><p id="Par14">The conventional MK model for continuous irradiation which considers discontinuous energy deposition to micrometre targets (or domains) is used for describing cell killing induced by DNA-TEs<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, where multi-fractionated exposures to cell population with a dose-delivery time <italic>T</italic> (h) and <italic>N</italic> dose fractions are assumed. Based on previous modelling<sup><xref ref-type="bibr" rid="CR10">10</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, the cell surviving fraction for DNA-TEs <italic>S</italic><sub>T</sub> can be given by:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{rcl}-\,\mathrm{ln}\,{S}_{{\rm{T}}} &#x00026; = &#x00026; {\sum }_{n=1}^{N}\,[({\alpha }_{0}\,+\,\gamma {\beta }_{0}){D}_{n}\Delta T\,+\,{\beta }_{0}{({D}_{n}\Delta T)}^{2}]\\  &#x00026;  &#x00026; +2{\sum }_{n=1}^{N-1}\,{\sum }_{m=n+1}^{N}\,[{\beta }_{0}\langle {e}^{-(m-n)(a+c)\Delta T}\rangle {D}_{n}{D}_{m}]\Delta {T}^{2}.\end{array}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mtable columnalign="left"><mml:mtr columnalign="left"><mml:mtd columnalign="right"><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mspace width=".25em"/><mml:mi>ln</mml:mi><mml:mspace width=".10em"/><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd><mml:mtd columnalign="center"><mml:mo>=</mml:mo></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mspace width=".25em"/><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mspace width=".25em"/><mml:mo>+</mml:mo><mml:mspace width=".25em"/><mml:mi>&#x003b3;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>&#x00394;</mml:mi><mml:mi>T</mml:mi><mml:mspace width=".25em"/><mml:mo>+</mml:mo><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:mi>&#x00394;</mml:mi><mml:mi>T</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr columnalign="left"><mml:mtd columnalign="left"/><mml:mtd columnalign="left"/><mml:mtd columnalign="left"><mml:mrow><mml:mo>+</mml:mo><mml:mn>2</mml:mn><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:mspace width=".25em"/><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>N</mml:mi></mml:mrow></mml:msubsup><mml:mspace width=".25em"/><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="true">&#x02329;</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>m</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi>n</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>&#x00394;</mml:mi><mml:mi>T</mml:mi></mml:mrow></mml:msup></mml:mrow><mml:mo stretchy="true">&#x0232a;</mml:mo></mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:mi>&#x00394;</mml:mi><mml:msup><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula>where <italic>&#x00394;T</italic> is a sub-section of <italic>T</italic> defined by <italic>T</italic>&#x02009;=&#x02009;<italic>N&#x00394;T</italic>, <italic>D</italic><sub><italic>n</italic></sub> is dose delivered to cell population in the period of <italic>&#x00394;T</italic>, <italic>&#x003b1;</italic><sub>0</sub> and <italic>&#x003b2;</italic><sub>0</sub> are the cell-specific coefficients for dose (Gy) and dose squared (Gy<sup>2</sup>), respectively; (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) is sum of constant rates for a PLL to transform into a LL and to be repaired (h<sup>&#x02212;1</sup>), representing approximately SLDR due to the relation of (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) <inline-formula id="IEq1"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\cong $$\end{document}</tex-math><mml:math id="M4"><mml:mo>&#x02245;</mml:mo></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq1.gif"/></alternatives></inline-formula>
<italic>c</italic><sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>; <italic>&#x003b3;</italic> (Gy) is the microdosimetric quantity expressed by <italic>&#x003b3;</italic>&#x02009;=&#x02009;<italic>y</italic><sub><italic>D</italic></sub>/(<italic>&#x003c1;&#x003c0;r</italic><sub>d</sub><sup>2</sup>); <italic>&#x003c1;</italic> and <italic>r</italic><sub>d</sub> represent the density of liquid water (1.0&#x02009;g/cm<sup>3</sup>) and radius of a domain<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> (set as 0.5 &#x003bc;m in this study); <italic>y</italic><sub><italic>D</italic></sub> is dose-mean lineal energy in keV/&#x003bc;m<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p><p id="Par15">Taking a limit of <italic>N</italic> to infinity, the surviving fraction for the continuous irradiation case, with a constant dose-rate <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\dot{D}$$\end{document}</tex-math><mml:math id="M6"><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq2.gif"/></alternatives></inline-formula> (Gy/h), can be expressed by using the Lea-Catcheside time factor <italic>F</italic> as follows:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{array}{c}-\,\mathrm{ln}\,{S}_{{\rm{T}}}=({\alpha }_{0}+\gamma {\beta }_{0})\dot{D}T+\frac{2{\beta }_{0}}{{(a+c)}^{2}{T}^{2}}[(a+c)T+{e}^{-(a+c)T}-1]{(\dot{D}T)}^{2}\\ \,\,\,\,=({\alpha }_{0}+\gamma {\beta }_{0})D+F{\beta }_{0}{D}^{2}\end{array}$$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mtable columnalign="left"><mml:mtr><mml:mtd><mml:mo>&#x02212;</mml:mo><mml:mspace width=".25em"/><mml:mi>ln</mml:mi><mml:mspace width=".10em"/><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>&#x003b3;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mi>T</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy="true">[</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>T</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo stretchy="true">]</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mi>T</mml:mi></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mspace width="1em"/><mml:mspace width="1em"/><mml:mspace width=".5em"/><mml:mspace width=".5em"/><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="true">(</mml:mo><mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mi>&#x003b3;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mo stretchy="true">)</mml:mo></mml:mrow><mml:mi>D</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where<disp-formula id="Equ3"><label>3a</label><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$F=\frac{2}{{(a+c)}^{2}{T}^{2}}[(a+c)T+{e}^{-(a+c)T}-1],$$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mi>F</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mn>2</mml:mn><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>T</mml:mi><mml:mo>+</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mi>T</mml:mi></mml:mrow></mml:msup><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">]</mml:mo><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ4"><label>3b</label><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D=\dot{D}T,$$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mi>D</mml:mi><mml:mo>=</mml:mo><mml:mover accent="true"><mml:mi>D</mml:mi><mml:mo>&#x002d9;</mml:mo></mml:mover><mml:mi>T</mml:mi><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where <italic>D</italic> is absorbed dose delivered to the cell population during the irradiation. In the model for DNA-targeted effects, (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) and <italic>&#x003b2;</italic><sub>0</sub> can be obtained from a split dose cell recovery curve, whilst <italic>&#x003b1;</italic><sub>0</sub> can be determined by fitting to the acute exposure cell survival curve.</p></sec><sec id="Sec9"><title>Modelling of intercellular communication (IC)</title><p id="Par16">The modelling of intercellular signalling between in-field and out-of-field cells is based on the IMK model, which incorporates the kinetics of signal concentration emitted from irradiated cells, DNA repair kinetics and cell survival<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. In the case of the half-field exposures considered here (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5 as shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>), we assume that the intercellular signals from in-field cells cover the entire out-of-field region (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>), based on previous experimental data<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. Concerning the time course of dose-delivery, the out-of-field surviving fraction appears to be independent of dose fractionation<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. So here, we made the following assumptions for NTEs:<list list-type="simple"><list-item><label>(i)</label><p id="Par17">Targets of micron-order size, which trigger the release of intercellular signals, exist somewhere within a cell, for example, mitochondria<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>. Intercellular cell-killing signals are emitted from target-activated cells (hit cells), and interact with cells without any activated targets (non-hit cells) in the flask. (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1D</xref>). The mean number of targets activated for releasing IC signals per hit cell is defined as (<inline-formula id="IEq3"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$({\alpha }_{{\rm{b}}}+\gamma {\beta }_{{\rm{b}}})D+{\beta }_{{\rm{b}}}{D}^{2}$$\end{document}</tex-math><mml:math id="M14"><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow></mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq3.gif"/></alternatives></inline-formula>), where <italic>&#x003b1;</italic><sub>b</sub> and <italic>&#x003b2;</italic><sub>b</sub> are coefficients for <italic>D</italic> and <italic>D</italic><sup>2</sup> for NTEs, respectively.</p></list-item><list-item><label>(ii)</label><p id="Par18">The probability of a given cell having an activated target for emitting NTE signals <italic>f</italic><sub>h</sub>(<italic>D</italic>) follows Poisson statistics with the number of activated targets for NTEs, giving <italic>f</italic><sub>h</sub>(<italic>D</italic>)&#x02009;=&#x02009;1&#x02212;<inline-formula id="IEq4"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${e}^{-[({\alpha }_{{\rm{b}}}+\gamma {\beta }_{{\rm{b}}})D+{\beta }_{{\rm{b}}}{D}^{2}]}$$\end{document}</tex-math><mml:math id="M16"><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow></mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq4.gif"/></alternatives></inline-formula><sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, where <italic>D</italic> denotes cumulative absorbed dose. The probability of a cell having no activated targets can be deduced as 1&#x02212;<italic>f</italic><sub>h</sub>(<italic>D</italic>). <italic>f</italic><sub>h</sub>(<italic>D</italic>) and <italic>f</italic><sub>b</sub>(<italic>D</italic>)&#x02009;=&#x02009;<inline-formula id="IEq5"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${e}^{-[({\alpha }_{{\rm{b}}}+\gamma {\beta }_{{\rm{b}}})D+{\beta }_{{\rm{b}}}{D}^{2}]}$$\end{document}</tex-math><mml:math id="M18"><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:mrow><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow></mml:mrow><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mrow><mml:mi>D</mml:mi></mml:mrow></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo stretchy="false">]</mml:mo></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq5.gif"/></alternatives></inline-formula>. This is taken to be independent of dose fractionation according to the experimental data from split-dose irradiation<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>.</p></list-item><list-item><label>(iii)</label><p id="Par19">To account for the generation of cell-killing signals, their decay and reaction with non-hit cells<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>, it is assumed that the yield of lethal lesions (LLs) in non-hit cells is proportional to the parameter <italic>&#x003b4;</italic><sup><xref ref-type="bibr" rid="CR34">34</xref></sup>, which is determined empirically.</p></list-item></list></p><p id="Par20">When delivering dose <italic>D</italic> (Gy) to the in-field region, the hit probability for in-field irradiated cells <italic>f</italic><sub>h</sub>(<italic>D</italic>)<sub>IF</sub> is equal to <inline-formula id="IEq6"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1-{e}^{-({\alpha }_{{\rm{b}}}+{\gamma }_{{\rm{I}}{\rm{F}}}{\beta }_{{\rm{b}}}){D}_{{\rm{I}}{\rm{F}}}-{\beta }_{{\rm{b}}}{{D}_{{\rm{I}}{\rm{F}}}}^{2}}$$\end{document}</tex-math><mml:math id="M20"><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq6.gif"/></alternatives></inline-formula>. The mean number of LLs per cells induced by NTEs <italic>w</italic><sub>NT</sub>, due to the effect of cell-killing signals from in-field area in the out-of-field area, can be expressed by using <italic>f</italic><sub>h</sub>(<italic>D</italic>), <italic>f</italic><sub>b</sub>(<italic>D</italic>) and <italic>&#x003b4;</italic> as follows:<disp-formula id="Equ5"><label>4</label><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${w}_{{\rm{NT}}}=\delta \,{f}_{{\rm{h}}}{(D)}_{{\rm{IF}}}\,{f}_{{\rm{b}}}{(D)}_{\ast }$$\end{document}</tex-math><mml:math id="M22" display="block"><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">NT</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>&#x003b4;</mml:mi><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">h</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi mathvariant="normal">IF</mml:mi></mml:mrow></mml:msub><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>D</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo>&#x0204e;</mml:mo></mml:mrow></mml:msub></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula>where <italic>f</italic><sub>b</sub>(<italic>D</italic>)<sub><italic>*</italic></sub> is the fraction of non-hit cells either in-field or out-of-field area (the symbol * stands for either in-field (IF) or out-of-field (OF)). Assuming Poisson statistics for the number of LLs per nucleus created by NTEs, the cell survival for NTEs can be expressed as<disp-formula id="Equ6"><label>5</label><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$-\,{\rm{l}}{\rm{n}}\,{S}_{{\rm{N}}{\rm{T}}}=\delta [1-\,{e}^{-({\alpha }_{{\rm{b}}}+{\gamma }_{{\rm{I}}{\rm{F}}}{\beta }_{{\rm{b}}}){D}_{{\rm{I}}{\rm{F}}}-{\beta }_{{\rm{b}}}{{D}_{{\rm{I}}{\rm{F}}}}^{2}}]{e}^{-({\alpha }_{{\rm{b}}}+{\gamma }_{\ast }{\beta }_{{\rm{b}}}){D}_{\ast }-{\beta }_{{\rm{b}}}{{D}_{\ast }}^{2}}$$\end{document}</tex-math><mml:math id="M24" display="block"><mml:mo>&#x02212;</mml:mo><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">n</mml:mi></mml:mrow><mml:mspace width="thinmathspace"/><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>&#x003b4;</mml:mi><mml:mo stretchy="false">[</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mspace width="thinmathspace"/><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b3;</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">I</mml:mi><mml:mi mathvariant="normal">F</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup><mml:mo stretchy="false">]</mml:mo><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b3;</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02217;</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02217;</mml:mo></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mrow><mml:mi mathvariant="normal">b</mml:mi></mml:mrow></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x02217;</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:msup></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>where <italic>S</italic><sub>NT</sub> is the surviving fraction of cells available for IC. The set of model parameters <italic>&#x003b1;</italic><sub>b</sub>, <italic>&#x003b2;</italic><sub>b</sub> and <italic>&#x003b4;</italic> are cell-specific and can be determined from fits to the experimental out-of-field cell survival curves.</p></sec><sec id="Sec10"><title>Cell surviving fraction considering TEs and NTE for modulated radiation fields</title><p id="Par21">Here, we stochastically consider the fraction of cells with which intercellular signals react, and from which the integrated surviving fraction for TEs and NTEs is deduced.</p><p id="Par22">Assuming that the interaction probability between sub-lesions (PLLs) in TEs and NTEs is very small<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>, the total number of LLs per nucleus considering TEs and NTEs (<italic>w</italic>) can be expressed by<disp-formula id="Equ7"><label>6</label><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$w={w}_{{\rm{T}}}+{w}_{{\rm{NT}}}=-\,\mathrm{ln}\,{S}_{\ast }$$\end{document}</tex-math><mml:math id="M26" display="block"><mml:mi>w</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">T</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>w</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">NT</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>&#x02212;</mml:mo><mml:mspace width="-.25em"/><mml:mi>ln</mml:mi><mml:mspace width=".10em"/><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x0204e;</mml:mo></mml:mrow></mml:msub></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula>where <italic>S</italic><sub><italic>*</italic></sub> is the surviving fraction of cells either in-field (<italic>S</italic><sub>IF</sub>) or out-of-field(<italic>S</italic><sub>OF</sub>). In Eq. (<xref rid="Equ7" ref-type="">6</xref>), it should be noted that the surviving fraction of cells for both half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) exposures is composed of the multiplication of survival for TEs and NTEs<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>.</p></sec><sec id="Sec11"><title>Model application and estimation of cell survival</title><p id="Par23">To determine the model parameters in the present model, we took 3 steps as follows: (i) calculation of <italic>y</italic><sub><italic>D</italic></sub> values by Monte Carlo simulation, (ii) determination of SLDR rate (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) and <italic>&#x003b2;</italic><sub>0</sub> from a split-dose cell recovery curve, (iii) fitting of the model to dose-response curves to determine the rest of the model parameters via Markov chain Monte Carlo (MCMC). We then estimated the surviving fraction by using the obtained model parameters.</p></sec><sec id="Sec12"><title>Monte carlo simulation to calculate <italic>y</italic><sub><italic>D</italic></sub> value</title><p id="Par24">We obtained <italic>y</italic><sub><italic>D</italic></sub> values for 225 kVp X-rays by using two Monte Carlo simulation codes, PHITS<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> and WLTrack<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>. The geometry is illustrated in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1A</xref>, which is validated by comparing the dose profile measured by Gafchromic film with that calculated by the PHITS simulation (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1B</xref>). The detail of geometry for calculating the <italic>y</italic><sub><italic>D</italic></sub> value is summarized in Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">I</xref> (<italic>&#x0201c;Monte Carlo Simulation for y</italic><sub><italic>D</italic></sub>
<italic>Calculation&#x0201d;</italic>).</p><p id="Par25">The calculated <italic>y</italic><sub><italic>D</italic></sub> values were 4.393&#x02009;&#x000b1;&#x02009;0.007&#x02009;keV/&#x003bc;m for the in-field area and 4.769&#x02009;&#x000b1;&#x02009;0.044&#x02009;keV/&#x003bc;m for the out-of-field area. These values were converted to <italic>&#x003b3;</italic> values and used as input parameters to describe the cell surviving fraction for each field area.</p></sec><sec id="Sec13"><title>Deduction of SLDR Rate from split-dose cell recovery</title><p id="Par26">According to previous reports of the MK model<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, the formula to calculate the (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) value, that is approximately equivalent to SLDR, is given by<disp-formula id="Equ8"><label>7</label><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$(a+c)=\frac{\mathop{\mathrm{lim}}\limits_{\tau \to 0}\frac{1}{S}\frac{{\rm{d}}S}{{\rm{d}}\tau }\,}{\mathrm{ln}\,\frac{S(\infty )}{S(0)}}$$\end{document}</tex-math><mml:math id="M28" display="block"><mml:mo stretchy="false">(</mml:mo><mml:mi>a</mml:mi><mml:mo>+</mml:mo><mml:mi>c</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:munder><mml:mrow><mml:mi>lim</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003c4;</mml:mi><mml:mo>&#x02192;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mi>S</mml:mi></mml:mfrac><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">d</mml:mi><mml:mi>&#x003c4;</mml:mi></mml:mrow></mml:mfrac><mml:mspace width=".25em"/></mml:mrow><mml:mrow><mml:mi>ln</mml:mi><mml:mspace width=".10em"/><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x0221e;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula>where <italic>&#x003c4;</italic> is inter-fraction time (incubation time between two irradiations) in hours, <italic>S</italic>(0) and <italic>S</italic>(<inline-formula id="IEq7"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\infty $$\end{document}</tex-math><mml:math id="M30"><mml:mi>&#x0221e;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq7.gif"/></alternatives></inline-formula>) are surviving fractions <italic>S</italic>(<inline-formula id="IEq8"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\tau $$\end{document}</tex-math><mml:math id="M32"><mml:mi>&#x003c4;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq8.gif"/></alternatives></inline-formula>) taking the limits of exposure interval (<inline-formula id="IEq9"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\tau \,\to \,0,\,\tau \,\to \,\infty $$\end{document}</tex-math><mml:math id="M34"><mml:mi>&#x003c4;</mml:mi><mml:mspace width=".25em"/><mml:mo>&#x02192;</mml:mo><mml:mspace width=".25em"/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mspace width=".25em"/><mml:mi>&#x003c4;</mml:mi><mml:mspace width=".25em"/><mml:mo>&#x02192;</mml:mo><mml:mspace width=".25em"/><mml:mi>&#x0221e;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq9.gif"/></alternatives></inline-formula>), respectively. In this study, the initial slope d<italic>S</italic>/d<italic>&#x003c4;</italic> was determined from the experimental surviving fraction by taking the gradient from 0 to 0.25&#x02009;h whilst <italic>S</italic>(&#x0221e;) was defined by the averaged survival from 6 to 48&#x02009;h. The <italic>&#x003b2;</italic><sub>0</sub> value can be also determined from the ratio of <italic>S</italic>(0) and <italic>S</italic>(<inline-formula id="IEq10"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\infty $$\end{document}</tex-math><mml:math id="M36"><mml:mi>&#x0221e;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq10.gif"/></alternatives></inline-formula>)<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> as expressed by:<disp-formula id="Equ9"><label>8</label><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\beta }_{0}\,=\,\frac{1}{2{D}_{1}{D}_{2}}\,\mathrm{ln}\,\frac{S(\infty )}{S(0)}$$\end{document}</tex-math><mml:math id="M38" display="block"><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mspace width=".25em"/><mml:mo>=</mml:mo><mml:mspace width=".25em"/><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>D</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mspace width=".25em"/><mml:mi>ln</mml:mi><mml:mspace width=".10em"/><mml:mfrac><mml:mrow><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>&#x0221e;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mn>0</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula>where <italic>D</italic><sub>1</sub> and <italic>D</italic><sub>2</sub> represent the first dose and second dose, respectively.</p><p id="Par27">Using Eqs (<xref rid="Equ8" ref-type="">7</xref>) and (<xref rid="Equ9" ref-type="">8</xref>), the set of model parameters involved in cell recovery between fractionated doses <italic>&#x003b8;</italic>&#x02009;=&#x02009;[<italic>&#x003b2;</italic><sub>0</sub>, (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>)] were deduced.</p></sec><sec id="Sec14"><title>MCMC simulation</title><p id="Par28">Using the obtained parameters of <italic>&#x003b8;</italic>&#x02009;=&#x02009;[<italic>&#x003b3;</italic>, <italic>&#x003b2;</italic><sub>0</sub>, (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>)], the rest of the cell-specific parameters in the IMK model <italic>&#x003b8;</italic>&#x02009;=&#x02009;(<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b1;</italic><sub>b</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>&#x003b4;</italic>) were determined via a MCMC technique established previously<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. The detail of the MCMC simulation is summarized in Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">II</xref> (<italic>&#x0201c;Markov chain Monte Carlo for Determining Model Parameters&#x0201d;</italic>). Particularly, it should be noted that the prior distribution of <italic>&#x003b8;</italic>&#x02009;=&#x02009;(<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b1;</italic><sub>b</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>&#x003b4;</italic>) and the uncertainty for &#x02013;ln <italic>S</italic> were set to follow a normal distribution.</p><p id="Par29">By applying the cell survival formulae (Eqs (<xref rid="Equ2" ref-type="">2</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>)) to experimental survival data after single-dose exposure (dose-response curve)<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup> in the MCMC simulation, we deduced the mean and standard deviation (s.d.) of the model parameters <italic>&#x003b8;</italic>&#x02009;=&#x02009;(<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b1;</italic><sub>b</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>&#x003b4;</italic>).</p></sec><sec id="Sec15"><title>Estimation of cell surviving fraction</title><p id="Par30">By the use of the obtained model parameters <italic>&#x003b8;</italic>&#x02009;=&#x02009;[<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b2;</italic><sub>0</sub>, (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>), <italic>&#x003b1;</italic><sub>b</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>&#x003b4;</italic>] and formulae of the IMK model (Eqs (<xref rid="Equ1" ref-type="">1</xref>), (<xref rid="Equ2" ref-type="">2</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>)), the surviving fraction for in-field and out-of-field cells for the cases of <italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5 and 1.0 were estimated.</p><p id="Par31">The cell survival curves after single-dose exposure were described based on Eqs (<xref rid="Equ2" ref-type="">2</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>), whilst the split-dose cell recovery curves, with two equal doses of 2&#x02009;Gy, were described according to Eqs (<xref rid="Equ1" ref-type="">1</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>). The fit quality for the fitting approach was checked by comparison with experimental survival obtained in this study and reference data<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR14">14</xref></sup>. As statistical measures, the coefficient of determination <italic>R</italic><sup>2</sup> and chi-square value were used, which are given by<disp-formula id="Equ10"><label>9a</label><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${R}^{2}={\rm{1}}-\frac{{\sum }_{i=1}^{n}\,{({\exp }_{i}-{{\rm{cal}}}_{i})}^{2}\,}{{\sum }_{i=1}^{n}\,{({\exp }_{i}- &#x0003c; \exp  &#x0003e; )}^{2}},$$\end{document}</tex-math><mml:math id="M40" display="block"><mml:msup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mn mathvariant="normal">1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mspace width=".25em"/><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>exp</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=".25em"/></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi mathvariant="normal">cal</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=".25em"/></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mspace width=".25em"/></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mspace width=".25em"/><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>exp</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=".25em"/></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mo>&#x0003c;</mml:mo><mml:mi>exp</mml:mi><mml:mo>&#x0003e;</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ11"><label>9b</label><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\chi }^{2}=\frac{1}{n}{\sum }_{i={\rm{1}}}^{n}\,\frac{{({\exp }_{i}-{{\rm{cal}}}_{i})}^{2}}{{\sigma }_{i\,\exp }^{2}}$$\end{document}</tex-math><mml:math id="M42" display="block"><mml:msup><mml:mrow><mml:mi>&#x003c7;</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac><mml:msubsup><mml:mrow><mml:mo>&#x02211;</mml:mo></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn mathvariant="normal">1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:msubsup><mml:mspace width=".25em"/><mml:mfrac><mml:mrow><mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mrow><mml:mi>exp</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=".25em"/></mml:mrow></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">cal</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=".25em"/></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msubsup><mml:mrow><mml:mi>&#x003c3;</mml:mi></mml:mrow><mml:mrow><mml:mi>i</mml:mi><mml:mspace width=".25em"/><mml:mi>exp</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:msubsup></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula>where exp<sub><italic>i</italic></sub> is measured cell survival, cal<sub><italic>i</italic></sub> is cell survival calculated by the present model and <italic>&#x003c3;</italic><sub>exp</sub> is the standard deviation of measured cell survival.</p><p id="Par32">To evaluate SLDR in a modulated field, we compared the model estimation (Eqs (<xref rid="Equ1" ref-type="">1</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>)) and experimental results for fractionated exposures with a total dose of 4&#x02009;Gy, delivered by the 4 regimens described in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>. For the dose response in the split-dose experiments, we also compared the model prediction (Eqs (<xref rid="Equ1" ref-type="">1</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>)) with the previous results reported by Ghita, <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The <italic>R</italic><sup>2</sup> value (Eq. (<xref rid="Equ10" ref-type="">9a</xref>)) was also used to check the fit quality of the cell recovery curve after fractionated irradiation and the dose response after a split-dose irradiation.</p></sec></sec><sec id="Sec16"><title>Results and Discussions</title><sec id="Sec17"><title>Split-dose cell recovery and dose-response curve</title><p id="Par33">Split-dose and single-dose experiments were performed to determine the degree of SLDR and the model parameters. Figure&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> shows the cell recovery curve for survival measured by a split-dose experiment in which upper and lower panels are the results for AGO1522 and DU145, respectively. The symbols in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> represent the experimental cell recovery. The survivals for the cases of <italic>&#x003c4;</italic>&#x02009;=&#x02009;0 and <inline-formula id="IEq11"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\infty $$\end{document}</tex-math><mml:math id="M44"><mml:mi>&#x0221e;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq11.gif"/></alternatives></inline-formula> (<italic>S</italic>(0) and <italic>S</italic>(<inline-formula id="IEq12"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\infty $$\end{document}</tex-math><mml:math id="M46"><mml:mi>&#x0221e;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq12.gif"/></alternatives></inline-formula>)) and the initial slop of d<italic>S</italic>/d<italic>&#x003c4;</italic> (dotted line in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) for in-field cells under uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2AI,BI</xref>) and in-field cells under half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2AII,BII</xref>) were used for determining the (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) and the <italic>&#x003b2;</italic><sub>0</sub> values based on Eqs (<xref rid="Equ8" ref-type="">7</xref>) and (<xref rid="Equ9" ref-type="">8</xref>). The obtained values (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) and <italic>&#x003b2;</italic><sub>0</sub> values are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<fig id="Fig2"><label>Figure 2</label><caption><p>Split-dose cell recovery curves to determine sub-lethal damage repair (SLDR). Upper and lower panels are experimental cell recovery curve (symbols) and the model (solid line) for AGO1522 and DU145, respectively. Doses of 4&#x02009;Gy were delivered using two equal fractions at various interfraction times (0, 0.25, 0.5, 1, 2, 4, 24, 48&#x02009;h). The cell survivals of <italic>S</italic>(0), <italic>S</italic>(<inline-formula id="IEq13"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\infty $$\end{document}</tex-math><mml:math id="M48"><mml:mi>&#x0221e;</mml:mi></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq13.gif"/></alternatives></inline-formula>) and the initial slope of cell recovery [<inline-formula id="IEq14"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathrm{lim}}_{\tau \to 0}(dS/d\tau )$$\end{document}</tex-math><mml:math id="M50"><mml:msub><mml:mrow><mml:mi>lim</mml:mi></mml:mrow><mml:mrow><mml:mi>&#x003c4;</mml:mi><mml:mo>&#x02192;</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>d</mml:mi><mml:mi>S</mml:mi><mml:mo>/</mml:mo><mml:mi>d</mml:mi><mml:mi>&#x003c4;</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq14.gif"/></alternatives></inline-formula>] were used to determine (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) and <italic>&#x003b2;</italic><sub>0</sub> values based on Eqs (<xref rid="Equ8" ref-type="">7</xref>) and (<xref rid="Equ9" ref-type="">8</xref>). The model parameters determined by the recovery curve are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.</p></caption><graphic xlink:href="41598_2019_45960_Fig2_HTML" id="d29e3201"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Model parameters for modulated and uniform radiation fields.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="2">Model parameter</th><th colspan="2">Type of cell line</th><th rowspan="2">Unit</th></tr><tr><th>AGO1522</th><th>DU145</th></tr></thead><tbody><tr><td rowspan="3">DNA-TEs for modulated field (MF)</td><td>
<italic>&#x003b1;</italic>
<sub>0</sub>
</td><td>0.363&#x02009;&#x000b1;&#x02009;0.013</td><td>0.032&#x02009;&#x000b1;&#x02009;0.006</td><td>Gy<sup>&#x02212;1</sup></td></tr><tr><td>
<italic>&#x003b2;</italic>
<sub>0</sub>
</td><td>0.011&#x02009;&#x000b1;&#x02009;0.020</td><td>0.039&#x02009;&#x000b1;&#x02009;0.013</td><td>Gy<sup>&#x02212;2</sup></td></tr><tr><td><italic>a</italic>&#x02009;+&#x02009;<italic>c</italic></td><td>0.034&#x02009;&#x000b1;&#x02009;0.062</td><td>2.509&#x02009;&#x000b1;&#x02009;1.267</td><td>h<sup>&#x02212;1</sup></td></tr><tr><td rowspan="3">DNA-TEs for uniform field (UF)</td><td>
<italic>&#x003b1;</italic>
<sub>0</sub>
</td><td>0.388&#x02009;&#x000b1;&#x02009;0.013</td><td>0.022&#x02009;&#x000b1;&#x02009;0.007</td><td>Gy<sup>&#x02212;1</sup></td></tr><tr><td>
<italic>&#x003b2;</italic>
<sub>0</sub>
</td><td>0.081&#x02009;&#x000b1;&#x02009;0.036</td><td>0.041&#x02009;&#x000b1;&#x02009;0.013</td><td>Gy<sup>&#x02212;2</sup></td></tr><tr><td><italic>a</italic>&#x02009;+&#x02009;<italic>c</italic></td><td>1.684&#x02009;&#x000b1;&#x02009;0.911</td><td>1.506&#x02009;&#x000b1;&#x02009;1.347</td><td>h<sup>&#x02212;1</sup></td></tr><tr><td rowspan="3">Intercellular communication</td><td>
<italic>&#x003b1;</italic>
<sub>b</sub>
</td><td>0.388&#x02009;&#x000b1;&#x02009;0.012</td><td>0.041&#x02009;&#x000b1;&#x02009;0.027</td><td>Gy<sup>&#x02212;1</sup></td></tr><tr><td>
<italic>&#x003b2;</italic>
<sub>b</sub>
</td><td>0.031&#x02009;&#x000b1;&#x02009;0.032</td><td>0.023&#x02009;&#x000b1;&#x02009;0.007</td><td>Gy<sup>&#x02212;2</sup></td></tr><tr><td>
<italic>&#x003b4;</italic>
</td><td>0.617&#x02009;&#x000b1;&#x02009;0.081</td><td>0.470&#x02009;&#x000b1;&#x02009;0.094</td><td>&#x02014;</td></tr></tbody></table><table-wrap-foot><p>The (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) and <italic>&#x003b2;</italic><sub>0</sub> values were deduced from experimental cell recovery curve shown in Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>. The rest of the model parameters were determined by fitting the present model to dose-response curves from single-dose exposures (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3A,B</xref>) via a MCMC simulation. By using the set of model parameters listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, cell surviving fractions for the cases of split-dose irradiation, single-dose irradiation and fractionated irradiation were calculated. The (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>)&#x02009;=&#x02009;0.034&#x02009;&#x000b1;&#x02009;0.062 (h<sup>&#x02212;1</sup>) of AGO1522 cells for modulated field exposure suggests that the SLDR rate is approximately 0, leading to no significant dose-rate dependence.</p></table-wrap-foot></table-wrap></p><p id="Par34">For AGO1522 cells, the (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) for modulated fields (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) was 0.034&#x02009;&#x000b1;&#x02009;0.062 (h<sup>&#x02212;1</sup>), whilst that for uniform fields (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) was 1.684&#x02009;&#x000b1;&#x02009;0.911 (h<sup>&#x02212;1</sup>). The value for uniform fields matches with the reported (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) value<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. However, in AGO1522 cells exposed to a modulated field, the mean value is less than the uncertainty, which suggests no significant dose-rate dependency. The <italic>&#x003b2;</italic><sub>0</sub> value is also reduced together with the reduced (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) value, which in the IMK model implies that the probability of two PLLs interacting might decrease or that the number of initial PLL is reduced<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. In contrast, experimental survival in DU145 cells exhibits the expected SLDR rates<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, i.e., (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>)&#x02009;=&#x02009;2.509&#x02009;&#x000b1;&#x02009;1.267 (h<sup>&#x02212;1</sup>) for a modulated field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>)&#x02009;=&#x02009;1.506&#x02009;&#x000b1;&#x02009;1.347 (h<sup>&#x02212;1</sup>) for a uniform field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0). Therefore a significant dose-rate dependence was observed for both radiation fields in DU145 cells. The comparison between <italic>in vitro</italic> data and the model suggests that the importance of SLDR in AGO1522 cells exposed to a modulated field is reduced relative to uniform field exposure. Finally, for both cell types there is no significant temporal dependence of out-of-field cell survival, suggesting that there is less impact of SLDR (DNA repair) on out-of-field cell-killing for both cell types (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2AIII,BIII</xref>).</p><p id="Par35">The experimental dose responses for cell surviving fraction are shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, where Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3A,B</xref> are the dose-survival relationship in AGO1522 and DU145, respectively. In Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, blue closed diamond, red triangle and green open diamond represent the experimental survival for in-field cells under half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5), out-of-field cells under half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and in-field cells under uniform-field exposures (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0), respectively. As shown in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, the cell viability under half-field exposure (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) is higher than that under uniform-field exposure (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0). The smaller colonies measured after 10&#x02009;Gy uniform-field exposure relative to those measured after half-field exposure are shown in Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">III</xref> (&#x0201c;<italic>Clonogenicity of In-Field Cells Under Modulated-Field Exposure</italic>&#x0201d;).<fig id="Fig3"><label>Figure 3</label><caption><p>Dose-response curve of cell survival after single-dose exposure. Blue closed diamond, red triangle and green open diamond represent the experimental survival of in-field cells for half-field, that of out-of-field cells for half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and that of in-field cells for uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0), respectively. The solid lines are the predicted curve based on DNA-TEs and IC (Eqs (<xref rid="Equ2" ref-type="">2</xref>), (<xref rid="Equ6" ref-type="">5</xref>), (<xref rid="Equ7" ref-type="">6</xref>)), while the dotted lines are the model prediction considering DNA-TEs only (Eq. (<xref rid="Equ2" ref-type="">2</xref>)). The parameters used are listed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. Experimental data for an exposure with <italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0 (100% shielded case) is shown as black open squares.</p></caption><graphic xlink:href="41598_2019_45960_Fig3_HTML" id="d29e3639"/></fig></p><p id="Par36">Based on these trends, we applied the parameter sets for DNA-TEs <italic>&#x003b8;</italic>&#x02009;=&#x02009;(<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) for each uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) and half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) exposure to fit full model parameter sets <italic>&#x003b8;</italic>&#x02009;=&#x02009;(<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>, <italic>&#x003b1;</italic><sub>b</sub>, <italic>&#x003b2;</italic><sub>b</sub>, <italic>&#x003b4;</italic>), which are summarized in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>. The predicted cell survival curves for single-dose irradiation are plotted as solid lines in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>, showing that the present model well reproduces the dose response curves for both in-field cells and the higher cell-killing of out-of-field cells at the same absorbed dose.</p><p id="Par37">It should be noted that the low-energy photons scattered from the lead shielding have the potential to enhance the out-of-field cell death in half-field exposures. This impact of the scattered photons on clonogenicity was therefore evaluated before the modelling approach with IC. As shown in Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">V</xref> (&#x0201c;<italic>Estimation of Impact of Low-Energy Photons on Out-of-Field Cell Survival</italic>&#x0201d;), there is no significant impact of scattered photons, with lower energy, on cell survival curve. In contrast, in the Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">IV</xref> (&#x0201c;<italic>Verification of the IMK model for Intercellular Communication</italic>&#x0201d;), previous data which showed that the out-of-field cell survival increased when cells were treated with a nitric oxide (NO) inhibitor<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> was well reproduced by the model prediction when IC was inhibited (<italic>&#x003b4;</italic>&#x02009;=&#x02009;0). From these results, it is clearly suggested that the decrease of out-of-field cell survival is attributed to signalling effects from in-field hit cells to out-of-field non-hits cells (cell killing induced by NO), which correspond to radiation-induced bystander effects<sup><xref ref-type="bibr" rid="CR16">16</xref>&#x02013;<xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par38">The reduction of radio-sensitivity for irradiated cells under modulated fields has been recently reported for the endpoints of cell survival<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> and apoptosis<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>; so called rescue<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> or protective effects<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Our <italic>in vitro</italic> survival data and the present model analysis (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>) are consistent with these recent reports<sup><xref ref-type="bibr" rid="CR22">22</xref>,<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR46">46</xref></sup>, showing a significant drop in the <inline-formula id="IEq15"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\beta }_{0}$$\end{document}</tex-math><mml:math id="M52"><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq15.gif"/></alternatives></inline-formula> term and SLDR (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) values in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) when AGO1522 cells are exposed to modulated fields, leading to increased radio-resistance of irradiated in-field cells compared to uniformly exposed cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).</p></sec><sec id="Sec18"><title>Cell recovery during multi-fractionation</title><p id="Par39">To evaluate the reduced importance of SLDR with half-field exposure, we next made a comparison of the model estimation with experimental data for the case of regimens delivered with 4 different dose-rates, i.e., 0.59&#x02009;Gy/min, 0.20&#x02009;Gy/min, 0.10&#x02009;Gy/min and 0.05&#x02009;Gy/min (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>). Figure&#x000a0;<xref rid="Fig4" ref-type="fig">4A,B</xref> show the comparison between the model estimation and experimental survival data. Blue circle, red triangle and green diamond in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4A,B</xref> represent the experimental data for in-field cells under half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5), out-of-field cells under half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and uniform-field exposed cells (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0), respectively. The mean value from the model estimation is described by solid line, and 95.4% confidence interval (CI) is shown by dotted line in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>. The 95.4% CI was calculated from the uncertainty deduced by the MCMC approach<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>.<fig id="Fig4"><label>Figure 4</label><caption><p>Dose-rate effects on cell survival. The temporal characteristics of the different averaged dose-rates are described in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1C</xref>. Blue, red, green symbols represent the experimental survival for in-field cells, out-of-field cells and uniformly exposed cells. The solid lines represent the mean survival estimated by using model parameters in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, the model formulae of Eqs (<xref rid="Equ1" ref-type="">1</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>). The dotted line indicates the 95.4% confidence interval (CI), which is calculated from the MCMC simulation.</p></caption><graphic xlink:href="41598_2019_45960_Fig4_HTML" id="d29e3870"/></fig></p><p id="Par40">From the experiments and modelling, whilst AGO1522 cells after uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) exposure exhibit significant cell recovery during dose-delivery, cells exposed to modulated fields see less SLDR and are more radio-resistant (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4A</xref>). In contrast, DU145 cells after uniform-field or half-field exposure exhibit similar recovery kinetics during dose-delivery (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4B</xref>).</p><p id="Par41">To further validate the different SLDR rate and radio-sensitivity in AGO1522 cells (Figs&#x000a0;<xref rid="Fig2" ref-type="fig">2A</xref>, <xref rid="Fig3" ref-type="fig">3A</xref> and <xref rid="Fig4" ref-type="fig">4A</xref>), we added the model predictions for the responses to split-dose irradiation. Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref> shows a comparison of AGO1522 cell survival curves estimated by the model (Eqs (<xref rid="Equ1" ref-type="">1</xref>), (<xref rid="Equ6" ref-type="">5</xref>) and (<xref rid="Equ7" ref-type="">6</xref>), Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>) and experiment data from Ghita <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. As shown in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>, the different sets of model parameters for half-field and uniform-field are able to reproduce the dose-response curves. This comparison confirms that the different radio-sensitivity created by modulated field results in lower <italic>&#x003b2;</italic><sub>0</sub> and (<italic>a</italic>&#x02009;+&#x02009;<italic>c</italic>) values for half-field relative to uniform-field exposures. The implications of this for clinical dose-delivery is summarized in the Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">VI</xref> (<italic>&#x0201c;Application to Clinical Dose-Delivery and Cell Survival Recovery&#x0201d;</italic>), where no statistically significant cell recovery of AGO1522 cells during irradiation using five different treatment modalities is reported.<fig id="Fig5"><label>Figure 5</label><caption><p>Estimation of cell survival after a split-dose exposure as a function of cumulative absorbed dose. (<bold>A</bold>) is for the case of half-field exposure and (<bold>B</bold>) is for the case of uniform-field, where blue, red, green symbols are the experimental survival for in-field, out-of-field and uniformly exposed cells, respectively. The experimental data were obtained from the previous report by Ghita, <italic>et al</italic>.<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. The data were modelled using the same procedure used in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>.</p></caption><graphic xlink:href="41598_2019_45960_Fig5_HTML" id="d29e3964"/></fig></p></sec><sec id="Sec19"><title>Cause of protective effects under half-field exposure</title><p id="Par42">The reason for the difference of in-field cell survival between half-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) and uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) exposure is still unclear. To better understand the radio-resistance induced by &#x0201c;protective effects&#x0201d;, we attempted to reproduce the survival curve for in-field cells where <italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5 by using the set of model parameters for the uniform field and different response assumptions. Two sets of assumptions were considered: (i) live cells move from the out-of-field region to the in-field region during incubation after irradiation<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>, or (ii) the initial DNA damage yield is reduced under modulated irradiation, which is predicted from the model analysis of <italic>&#x003b2;</italic><sub>0</sub> values (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. From these assumptions, we attempted to determine the processes leading to radio-resistance.</p><p id="Par43">For cell migration, we assumed a fraction <inline-formula id="IEq16"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{{\rm{move}}}$$\end{document}</tex-math><mml:math id="M54"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">move</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2019_45960_Article_IEq16.gif"/></alternatives></inline-formula> of cells move between the in-field and out-of-field regions during incubation after irradiation, and those with no lethal DNA lesions contribute to the surviving fraction. Thus, the measured in-field surviving fraction considering the two cell populations can be given as,<disp-formula id="Equ12"><label>10</label><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$S=(1-{f}_{{\rm{move}}})\,{S}_{{\rm{IF}}}+{f}_{{\rm{move}}}\,{S}_{{\rm{M}}},$$\end{document}</tex-math><mml:math id="M56" display="block"><mml:mi>S</mml:mi><mml:mo>=</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">move</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">IF</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">move</mml:mi></mml:mrow></mml:msub><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi>S</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">M</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ12.gif" position="anchor"/></alternatives></disp-formula>where <italic>S</italic><sub>IF</sub> is the surviving fraction for the in-field cells which were originally present during irradiation, <italic>S</italic><sub>M</sub> is the surviving fraction for the surviving out-of-field cells which have migrated from the out-of-field area (<italic>S</italic><sub>M</sub>&#x02009;=&#x02009;1.0), and <italic>S</italic> is the total surviving fraction of the combined cell population. Applying the model (Eqs (<xref rid="Equ2" ref-type="">2</xref>), (<xref rid="Equ6" ref-type="">5</xref>), (<xref rid="Equ7" ref-type="">6</xref>) and (<xref rid="Equ12" ref-type="">10</xref>)) to the experimental in-field survival data, we obtained <italic>f</italic><sub>move</sub>&#x02009;=&#x02009;0.096&#x02009;&#x000b1;&#x02009;0.011 as shown in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6A</xref>. The model predicts that 9.55% of the surviving out-of-field cells migrate to the in-field area, giving rise to a roughly constant cell survival in high-dose range above about 6&#x02009;Gy (blue dotted line in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6A</xref>). However, there is no experimental evidence for this, at least <italic>in vitro</italic>. For example, Butterworth, <italic>et al</italic>. performed clonogenic assays quantifying the out-of-field cell survival at high dose (35&#x02009;Gy in-field dose) and indicated that there were no colonies surviving in the in-field region<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Overall, this suggests that migration is not a major factor in the induction of radio-resistance.<fig id="Fig6"><label>Figure 6</label><caption><p>Estimation of the protective effects induced by modulated irradiation. (<bold>A</bold>) Predicted cell survival considering cell migration, in which we assumed that some cells from the shielded population migrate into the in-field area. (<bold>B</bold>) Predicted cell survival considering a reduced the DNA damage yield under half-field exposure. The reduced DNA damage yield is incorporated into the IMK model by using the <italic>k</italic><sub>half</sub>/<italic>k</italic><sub>uniform</sub>, where <italic>k</italic><sub>half</sub> is the number of PLLs per Gy for half-field and <italic>k</italic><sub>uniform</sub> is that for uniform-field.</p></caption><graphic xlink:href="41598_2019_45960_Fig6_HTML" id="d29e4165"/></fig></p><p id="Par44">Next, we estimated the cell survival curve based on modifying the initial DNA damage yields. Previous DNA damage studies showed a smaller number of DNA lesions (detected by 53BP1 foci) after half-field exposure (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5) than the uniform-field exposure (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0)<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup>. We incorporated this reduced DNA damage yield into the dose coefficients (<italic>&#x003b1;</italic><sub>0</sub>, <italic>&#x003b2;</italic><sub>0</sub>) in the DNA-TEs model<sup><xref ref-type="bibr" rid="CR35">35</xref></sup> according to the equation:<disp-formula id="Equ13"><label>11</label><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\alpha }_{0}=\frac{ak}{c}\,{\rm{and}}\,{\beta }_{0}=\frac{b{k}^{2}}{2c},$$\end{document}</tex-math><mml:math id="M58" display="block"><mml:msub><mml:mrow><mml:mi>&#x003b1;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>a</mml:mi><mml:mi>k</mml:mi></mml:mrow><mml:mi>c</mml:mi></mml:mfrac><mml:mspace width=".25em"/><mml:mi mathvariant="normal">and</mml:mi><mml:mspace width=".25em"/><mml:msub><mml:mrow><mml:mi>&#x003b2;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>b</mml:mi><mml:msup><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>c</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:math><graphic xlink:href="41598_2019_45960_Article_Equ13.gif" position="anchor"/></alternatives></disp-formula>where <italic>a</italic> is the rate constant for a PLL to transform into a LL (h<sup>&#x02212;1</sup>), <italic>b</italic> is the rate constant for two PLLs to interact and transform into a LL and <italic>c</italic> is the rate constant for PLL to be repaired. The experimental DNA damage yield ratio, i.e., 0.642&#x02009;&#x000b1;&#x02009;0.110 (=<italic>k</italic><sub>half</sub>/<italic>k</italic><sub>uniform</sub>)<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> modifies the survival curve of the in-field irradiated cells to agree well with experimental data (blue solid line in Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6B</xref>) with a smaller <italic>&#x003c7;</italic><sup>2</sup> value than the model based on cell migration. Overall, as interpreted from the reduced <italic>&#x003b2;</italic><sub>0</sub> value (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), we concluded that the reduced initial DNA damage induction due to IC might play a key role of inducing radio-resistance (protective effects) after modulated-field exposure.</p></sec><sec id="Sec20"><title>DNA damage mediated cell-cycle effects</title><p id="Par45">Finally, to test the impact of modulated fields on DNA damage mediated checkpoint inhibition, cell-cycle studies were performed. Figure&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref> shows the dynamics of cell-cycle distribution (fractions of cells in G<sub>1</sub>, S and G<sub>2</sub>/M phases) after irradiation, where (A) is for AGO1522 cells and (B) is for DU145 cells.<fig id="Fig7"><label>Figure 7</label><caption><p>Cell-cycle kinetics after uniform and half field radiation exposure: (<bold>A</bold>) Measured cell-cycle changes after the exposure of AGO1522 cells, (<bold>B</bold>) for DU145 cells. Blue and red symbols represent the fractions of the in-field and out-of-field cells following half-field exposure (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5), whilst the green symbol represents uniformly irradiated cells (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0). * and ** indicate 5% and 1% significant differences from the previous cell-cycle fraction (i.e., 0&#x02009;h and 6&#x02009;h, 6&#x02009;h and 24&#x02009;h, 24&#x02009;h and 72&#x02009;h).</p></caption><graphic xlink:href="41598_2019_45960_Fig7_HTML" id="d29e4339"/></fig></p><p id="Par46">In the AGO1522 cells exposed to 4&#x02009;Gy with uniform-field (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;1.0) (green symbol in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7A</xref>), we observed a significant G<sub>2</sub> block 6&#x02009;h after irradiation and a cell accumulation at the G<sub>1</sub> checkpoint 24&#x02009;h after the irradiation. Under the half-field exposure (<italic>A</italic><sub>IF</sub>&#x02009;=&#x02009;0.5), the population of in-field cells maintains the original cell-cycle distribution until 6&#x02009;h after irradiation (blue symbol in left panel of Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7A</xref>). In contrast, the out-of-field AGO1522 cells exhibit an accumulation in the G<sub>1</sub> phase, which might be related to the signal-induced cell-killing. DU145 cells exposed uniformly to 8&#x02009;Gy are blocked in G<sub>2</sub> 6&#x02009;h after irradiation with no G<sub>1</sub> block observed up to 24&#x02009;h after the irradiation (green symbol in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7B</xref>). This is because DU145 cells are p53 mutant<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. However, the same (constant) cell-cycle dynamics were observed in the DU145 cells up to 6&#x02009;h after irradiation in out-of-field populations.</p><p id="Par47">Cell cycle checkpoints are intrinsically related to the degree of DNA damage induction after irradiation<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>. Thus, it is reasonable to assume that the stable cell-cycle distribution after half-field exposure (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>) results from the reduced DNA damage (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6B</xref>). We also suspected the involvement of NO in protective effects because of its involvement in out-of-field cell killing<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. An additional cell-cycle study with 100 &#x003bc;M aminoguanidine (AG) as an inhibitor of NO was also performed, however AG, under the conditions tested, does not appear alter the cell-cycle distribution, as described in the Supplementary Information&#x000a0;<xref rid="MOESM1" ref-type="media">VII</xref> (<italic>&#x0201c;Cell-Cycle Study with AG Treatment for Modulated Radiation Field&#x0201d;</italic>). The scenario for cell responses in modulated fields is that: (i) there is a reduced initial induction of DNA damage, (ii) cell-cycle checkpoints are not activated due to the reduced DNA damage, and (iii) this reduced DNA damage leads to an increased radio-resistance (and apparent protective effects). However, DNA damage repair within 30&#x02009;min after irradiation as well as the bystander cross talk have not been examined here, so further investigation of what causes the reduced DNA damage is necessary.</p></sec></sec><sec id="Sec21" sec-type="conclusion"><title>Conclusion</title><p id="Par48">In this study, we evaluated the impact of modulated radiation fields on the radio-sensitivity and dose-rate effects in human skin fibroblast (AGO1522) and human prostate cancer (DU145) cells. From the <italic>in vitro</italic> experiments and the model analysis, modulated radiation exposures: (i) reduce the yield of PLLs and the importance of cell recovery (SLDR), and (ii) reduce the radio-sensitivity of in-field cells compared to conventional uniform exposures. These effects can be explained by the reduction of the DNA damage in the modulated field, which may also impact on cell-cycle distribution. However, the biological mechanisms governing this change in initial DNA damage remain unclear, so further studies are necessary to identify the underlying mechanisms.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec22"><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41598_2019_45960_MOESM1_ESM.pdf"><caption><p>Supplementary data</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note:</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p><bold>Supplementary information</bold> accompanies this paper at 10.1038/s41598-019-45960-z.</p></sec><notes notes-type="author-contribution"><title>Author Contributions</title><p>Y. Matsuya, S.J. McMahon and K.M. Prise designed the study. Y. Matsuya and M. Ghita performed experiments. Y. Matsuya developed the model and calculated cell survival. Y. Matsuya, Y. Yoshii, T. Sato and H. Date calculated dose-mean lineal energy by Monte Carlo codes for transporting the radiation particles. Y. Matsuya and S.J. McMahon wrote the manuscript. K.M. Prise supervised the study. All authors reviewed the manuscript.</p></notes><notes notes-type="COI-statement"><title>Competing Interests</title><p id="Par49">The authors declare no competing interests.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGarry</surname><given-names>CK</given-names></name><etal/></person-group><article-title>Temporal characterization and <italic>in vitro</italic> comparison of cell survival following the delivery of 3Dconformal, intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT)</article-title><source>Phys. Med. Biol.</source><year>2011</year><volume>56</volume><fpage>2445</fpage><lpage>2457</lpage><pub-id pub-id-type="doi">10.1088/0031-9155/56/8/008</pub-id><pub-id pub-id-type="pmid">21427488</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garibaldi</surname><given-names>E</given-names></name><name><surname>Gabriele</surname><given-names>D</given-names></name><name><surname>Maggio</surname><given-names>A</given-names></name><name><surname>Delmastro</surname><given-names>E</given-names></name></person-group><article-title>External beam radiotherapy with dose escalation in 1080 prostate cancer patients: definitive outcome and dose impact</article-title><source>Panminerva Med.</source><year>2016</year><volume>58</volume><fpage>121</fpage><lpage>129</lpage><?supplied-pmid 26785374?><pub-id pub-id-type="pmid">26785374</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelsson</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>SC</given-names></name><name><surname>Gladstone</surname><given-names>DJ</given-names></name><name><surname>Pogue</surname><given-names>BW</given-names></name></person-group><article-title>Cerenkov emission induced by external beam radiation stimulates molecular fluorescence</article-title><source>Med. Phys.</source><year>2011</year><volume>38</volume><issue>7</issue><fpage>4127</fpage><lpage>4132</lpage><pub-id pub-id-type="doi">10.1118/1.3592646</pub-id><pub-id pub-id-type="pmid">21859013</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>HD</given-names></name><name><surname>Glasgow</surname><given-names>GP</given-names></name><name><surname>Pethel</surname><given-names>TD</given-names></name><name><surname>Thomadsen</surname><given-names>BR</given-names></name><name><surname>Williamson</surname><given-names>JF</given-names></name></person-group><article-title>High dose-rate brachytherapy treatment delivery: Report of the AAPM Radiation Therapy Committee Task Group No. 59</article-title><source>Med. Phys.</source><year>1998</year><volume>25</volume><issue>4</issue><fpage>375</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1118/1.598232</pub-id><pub-id pub-id-type="pmid">9571605</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kishan</surname><given-names>AU</given-names></name><name><surname>Lee</surname><given-names>P</given-names></name></person-group><article-title>MRI-guided radiotherapy: Opening our eyes to the future</article-title><source>Integr. Cancer Sci. Therap.</source><year>2016</year><volume>3</volume><issue>2</issue><fpage>420</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.15761/ICST.1000181</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dasu</surname><given-names>A</given-names></name><name><surname>Toma-Dasu</surname><given-names>I</given-names></name></person-group><article-title>Will intrafraction repair have negative consequences on extreme hypofractionation in prostate radiation therapy?</article-title><source>Br. J. Radiol.</source><year>2015</year><volume>88</volume><issue>l</issue><fpage>20150588</fpage><pub-id pub-id-type="doi">10.1259/bjr.20150588</pub-id><pub-id pub-id-type="pmid">26449127</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuperman</surname><given-names>VY</given-names></name><name><surname>Ventura</surname><given-names>AM</given-names></name><name><surname>Sommerfeldt</surname><given-names>M</given-names></name></person-group><article-title>Effect of radiation protraction in intensity- modulated radiation therapy with direct aperture optimization: a phantom study</article-title><source>Phys. Med. Biol.</source><year>2008</year><volume>53</volume><fpage>3279</fpage><lpage>3292</lpage><pub-id pub-id-type="doi">10.1088/0031-9155/53/12/014</pub-id><pub-id pub-id-type="pmid">18523349</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkind</surname><given-names>MM</given-names></name><name><surname>Sutton</surname><given-names>H</given-names></name></person-group><article-title>Radiation response of mammalian cells grown in culture. I. Repair of X-ray damage in surviving Chinese hamster cells</article-title><source>Radiat. Res.</source><year>1960</year><volume>13</volume><fpage>556</fpage><lpage>593</lpage><pub-id pub-id-type="doi">10.2307/3570945</pub-id><pub-id pub-id-type="pmid">13726391</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elkind</surname><given-names>MM</given-names></name></person-group><article-title>Repair processes in radiation biology</article-title><source>Radiat. Res.</source><year>1984</year><volume>100</volume><fpage>425</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.2307/3576409</pub-id><pub-id pub-id-type="pmid">6390488</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuya</surname><given-names>Y</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Date</surname><given-names>H</given-names></name></person-group><article-title>Markov chain Monte Carlo analysis for the selection of a cell-killing model under high-dose-rate irradiation</article-title><source>Med. Phys.</source><year>2017</year><volume>44</volume><issue>10</issue><fpage>5522</fpage><lpage>5532</lpage><pub-id pub-id-type="doi">10.1002/mp.12508</pub-id><pub-id pub-id-type="pmid">28786486</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterworth</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Out-of-field cell survival following exposure to intensity modulated radiation fields</article-title><source>Int. J. Radiat. Oncol. Biol. Phys.</source><year>2011</year><volume>79</volume><issue>5</issue><fpage>1516</fpage><lpage>1522</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2010.11.034</pub-id><pub-id pub-id-type="pmid">21277116</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trainor</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cell survival responses after exposure to modulated radiation fields</article-title><source>Radiat. Res.</source><year>2012</year><volume>51</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1667/RR2656.1</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghita.</surname><given-names>M</given-names></name><etal/></person-group><article-title>Impact of fractionation on out-of-field survival and DNA damage responses following exposure to intensity modulated radiation fields</article-title><source>Phys. Med. Biol.</source><year>2015</year><volume>61</volume><issue>2</issue><fpage>515</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1088/0031-9155/61/2/515</pub-id><pub-id pub-id-type="pmid">26683123</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterworth</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Dose, dose-rate and field size effects on cell survival following exposure to non-uniform radiation fields</article-title><source>Phys. Med. Biol.</source><year>2012</year><volume>57</volume><fpage>3197</fpage><lpage>3206</lpage><pub-id pub-id-type="doi">10.1088/0031-9155/57/10/3197</pub-id><pub-id pub-id-type="pmid">22546687</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>A Kinetic-Based Model of Radiation-Induced Intercellular Signalling</article-title><source>PloS One</source><year>2012</year><volume>8</volume><fpage>e54526</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0054526</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>H</given-names></name><name><surname>Little</surname><given-names>JB</given-names></name></person-group><article-title>Induction of sister chromatid exchanges by extremely low doses of &#x003b1;- particles</article-title><source>Can. Res.</source><year>1992</year><volume>52</volume><issue>22</issue><fpage>6394</fpage><lpage>6396</lpage></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagasawa</surname><given-names>H</given-names></name><name><surname>Little</surname><given-names>JB</given-names></name></person-group><article-title>Unexpected sensitivity to the induction of mutations by very low doses of alpha-particle radiation: evidence for a bystander effect</article-title><source>Radiat. Res.</source><year>1999</year><volume>152</volume><issue>5</issue><fpage>552</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.2307/3580153</pub-id><pub-id pub-id-type="pmid">10521933</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>WF</given-names></name><name><surname>Sowa</surname><given-names>MB</given-names></name></person-group><article-title>Non-targeted bystander effects induced by ionizing radiation</article-title><source>Mutat. Res.</source><year>2007</year><volume>616</volume><issue>1</issue><fpage>159</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2006.11.009</pub-id><pub-id pub-id-type="pmid">17134726</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prise</surname><given-names>KM</given-names></name><name><surname>O&#x02019;Sullivan</surname><given-names>JM</given-names></name></person-group><article-title>Radiation-induced bystander signalling in cancer therapy</article-title><source>Nature Reviews Cancer</source><year>2009</year><volume>9</volume><fpage>351</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1038/nrc2603</pub-id><pub-id pub-id-type="pmid">19377507</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterworth</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Time and Cell Type Dependency of Survival Responses in Co-cultured Tumor and Fibroblast Cells after Exposure to Modulated Radiation Fields</article-title><source>Radiat. Res.</source><year>2015</year><volume>183</volume><fpage>656</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1667/RR13992.1</pub-id><pub-id pub-id-type="pmid">25973952</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>H</given-names></name><etal/></person-group><article-title>Induction of Radioresistance by a Nitric Oxide-Mediated Bystander Effect</article-title><source>Radiat. Res.</source><year>2011</year><volume>155</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="doi">10.1667/0033-7587(2001)155[0387:IORBAN]2.0.CO;2</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>RKK</given-names></name><name><surname>Fung</surname><given-names>YK</given-names></name><name><surname>Han</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>KN</given-names></name></person-group><article-title>Rescue Effects: Irradiated Cells Helped by Unirradiated Bystander Cells</article-title><source>Int. J. Mol. Sci.</source><year>2015</year><volume>16</volume><issue>2</issue><fpage>2591</fpage><lpage>2609</lpage><pub-id pub-id-type="doi">10.3390/ijms16022591</pub-id><pub-id pub-id-type="pmid">25625514</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>S</given-names></name><etal/></person-group><article-title>Rescue effects in radiobiology: Unirradiated bystander cells assist irradiated cells through intercellular signal feedback</article-title><source>Mutat. Res.</source><year>2011</year><volume>706</volume><issue>1&#x02013;2</issue><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2010.10.011</pub-id><pub-id pub-id-type="pmid">21073884</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">Bentzen, S. M. &#x00026; Joiner, M. C. The linear-quadratic approach in clinical practice. In: Joiner, M, van der Kogel, A. J., eds. Basic clinical radiobiology. London: Hodder Arnold; 120&#x02013;134 (2009).</mixed-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>DJ</given-names></name></person-group><article-title>The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction</article-title><source>Semin. Radiat. Oncol.</source><year>2008</year><volume>18</volume><fpage>234</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1016/j.semradonc.2008.04.004</pub-id><pub-id pub-id-type="pmid">18725109</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Hall, E. J. &#x00026; Giaccia, A. J. Time, Dose, and Fractionation in Radiotherapy. In: Hall, E. J., Giaccia, A. J. Radiobiology for the Radiologist 6th ed. Philadelphia: Lippincott Williams &#x00026; Wilkins: 378&#x02013;379 (2006).</mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>SJ</given-names></name></person-group><article-title>The linear quadratic model: usage, interpretation and challenges</article-title><source>Phys. Med. Biol.</source><year>2019</year><volume>64</volume><issue>1</issue><fpage>01TR01</fpage><pub-id pub-id-type="doi">10.1088/1361-6560/aaf26a</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>RB</given-names></name></person-group><article-title>A microdosimetric-kinetic model of cell death from exposure to ionizing radiation of any LET, with experimental and clinical applications</article-title><source>Int. J. Radiat. Biol.</source><year>1996</year><volume>69</volume><fpage>739</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1080/095530096145481</pub-id><pub-id pub-id-type="pmid">8691026</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">ICRU. Microdosimetry. Report 36. International Commission on Radiation Units and Measurements. Bethesda: MD (1983).</mixed-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inaniwa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effects of dose-delivery time structure on biological effectiveness for therapeutic carbon-ion beams evaluated with microdosimetric kinetic model</article-title><source>Radiat. Res.</source><year>2013</year><volume>180</volume><fpage>44</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1667/RR3178.1</pub-id><pub-id pub-id-type="pmid">23768075</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuya</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Modeling cell survival and change in amount of DNA during protracted irradiation</article-title><source>J. Radiat. Res.</source><year>2017</year><volume>58</volume><issue>3</issue><fpage>302</fpage><lpage>312</lpage><?supplied-pmid 27974510?><pub-id pub-id-type="pmid">27974510</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>ZF</given-names></name><etal/></person-group><article-title>Effective target size for the induction of bystander effects in medium transfer experiments</article-title><source>Radiat. Res.</source><year>2007</year><volume>168</volume><fpage>627</fpage><lpage>630</lpage><pub-id pub-id-type="doi">10.1667/RR1014.1</pub-id><pub-id pub-id-type="pmid">17973551</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedland</surname><given-names>W</given-names></name><name><surname>Kundr&#x000e1;t</surname><given-names>P</given-names></name><name><surname>Jacob</surname><given-names>P</given-names></name></person-group><article-title>Track structure calculation on hypothetical subcellular targets for the release of cell-killing signals in bystander experiments with medium</article-title><source>Radiat. Prot. Dos.</source><year>2011</year><volume>143</volume><issue>2&#x02013;4</issue><fpage>325</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1093/rpd/ncq401</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuya</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>K</given-names></name><name><surname>Yoshii</surname><given-names>Y</given-names></name><name><surname>Okuyama</surname><given-names>G</given-names></name><name><surname>Date</surname><given-names>H</given-names></name></person-group><article-title>Integrated Modelling of Cell Responses after irradiation for DNA-Targeted Effects and Non-Targeted Effects</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>4849</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-23202-y</pub-id><pub-id pub-id-type="pmid">29555939</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuya</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Investigation of dose-rate effects and cell-cycle distribution under protracted exposure to ionizing radiation for various dose-rates</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>8287</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-26556-5</pub-id><pub-id pub-id-type="pmid">29844494</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Sato, T. <italic>et al</italic>. Features of Particle and Heavy Ion Transport code System (PHITS) version 3.02. <italic>J. Nucl. Sci. Technol</italic>.1881&#x02013;1248 Online (2018).</mixed-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>HF</given-names></name><etal/></person-group><article-title>The impact of hypoxia on out-of-field cell survival after exposure to modulated radiation fields</article-title><source>Radiat. Res.</source><year>2017</year><volume>188</volume><issue>6</issue><fpage>636</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1667/RR14836.1</pub-id><pub-id pub-id-type="pmid">29019742</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>RB</given-names></name><name><surname>Inaniwa</surname><given-names>T</given-names></name></person-group><article-title>A microdosimetric-kinetic model for cell killing by protracted continuous irradiation including dependence on LET I: repair in cultured mammalian cells</article-title><source>Radiat. Res.</source><year>2013</year><volume>180</volume><fpage>584</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1667/RR13257.1</pub-id><pub-id pub-id-type="pmid">24191898</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okamoto</surname><given-names>H</given-names></name><etal/></person-group><article-title>Relation between lineal energy distribution and relative biological effectiveness for photon beams according to the microdosimetric kinetic model</article-title><source>J. Radiat. Res.</source><year>2011</year><volume>52</volume><issue>1</issue><fpage>75</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1269/jrr.10073</pub-id><pub-id pub-id-type="pmid">21160135</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hei</surname><given-names>TK</given-names></name><etal/></person-group><article-title>Mechanism of radiation&#x02010;induced bystander effects: a unifying model</article-title><source>J. Pharm. Pharmacol.</source><year>2008</year><volume>60</volume><issue>8</issue><fpage>943</fpage><lpage>950</lpage><pub-id pub-id-type="doi">10.1211/jpp.60.8.0001</pub-id><pub-id pub-id-type="pmid">18644187</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kundr&#x000e1;t</surname><given-names>P</given-names></name><name><surname>Friedland</surname><given-names>W</given-names></name><name><surname>Friedland</surname><given-names>W</given-names></name></person-group><article-title>Mechanistic modelling of radiation-induced bystander effects</article-title><source>Radiat. Prot. Dos.</source><year>2015</year><volume>166</volume><fpage>148</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1093/rpd/ncv170</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trainor</surname><given-names>C</given-names></name><etal/></person-group><article-title>DNA Damage Responses following Exposure to Modulated Radiation Fields</article-title><source>PLoS ONE.</source><year>2012</year><volume>7</volume><issue>8</issue><fpage>e43326</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0043326</pub-id><pub-id pub-id-type="pmid">22912853</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other">Sato, T. &#x00026; Hamada, N. Model Assembly for Estimating Cell Surviving Fraction for Both Targeted and Nontargeted Effects Based on Microdosimetric Probability Densities. <italic>PloS ONE</italic>, e114056 (2014).</mixed-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Date</surname><given-names>H</given-names></name><name><surname>Sutherland</surname><given-names>KL</given-names></name><name><surname>Hasegawa</surname><given-names>H</given-names></name><name><surname>Shimozuma</surname><given-names>M</given-names></name></person-group><article-title>Ionization and excitation collision processes of electrons in liquid water</article-title><source>Nucl. Instr. Meth. B.</source><year>2007</year><volume>265</volume><issue>2</issue><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.nimb.2007.09.039</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adrian</surname><given-names>G</given-names></name><name><surname>Ceberg</surname><given-names>C</given-names></name><name><surname>Carneiro</surname><given-names>A</given-names></name><name><surname>Ekblad</surname><given-names>L</given-names></name></person-group><article-title>Rescue Effect Inherited in Colony Formation Assays Affects Radiation Response</article-title><source>Radiat. Res.</source><year>2018</year><volume>189</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1667/RR14842.1</pub-id><pub-id pub-id-type="pmid">29136392</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Widela</surname><given-names>M</given-names></name><name><surname>Przybyszewskib</surname><given-names>WM</given-names></name><name><surname>Cieslar-Pobudaa</surname><given-names>A</given-names></name><name><surname>Saenkoc</surname><given-names>YV</given-names></name><name><surname>Rzeszowska-Wolny</surname><given-names>J</given-names></name></person-group><article-title>Bystander normal human fibroblasts reduce damage response in radiation targeted cancer cells through intercellular ROS level modulation</article-title><source>Mutat. Res.</source><year>2012</year><volume>731</volume><fpage>117</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2011.12.007</pub-id><pub-id pub-id-type="pmid">22210495</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coates</surname><given-names>PJ</given-names></name><name><surname>Lorimore</surname><given-names>SA</given-names></name><name><surname>Wright</surname><given-names>EG</given-names></name></person-group><article-title>Damaging and protective cell signaling in the untargeted effects of ionizing radiation</article-title><source>Mutat. Res.</source><year>2004</year><volume>568</volume><fpage>5</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2004.06.042</pub-id><pub-id pub-id-type="pmid">15530535</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wild-Bode</surname><given-names>C</given-names></name><name><surname>Weller</surname><given-names>M</given-names></name><name><surname>Rimner</surname><given-names>A</given-names></name><name><surname>Dichgans</surname><given-names>J</given-names></name><name><surname>Wick</surname><given-names>W</given-names></name></person-group><article-title>Sublethal Irradiation Promotes Migration and Invasiveness of Glioma Cells: Implications for Radiotherapy of Human Glioblastoma</article-title><source>Canc. Res.</source><year>2001</year><volume>61</volume><fpage>2744</fpage><lpage>2750</lpage></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambrosini</surname><given-names>G</given-names></name><etal/></person-group><article-title>Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1</article-title><source>Oncogene</source><year>2007</year><volume>26</volume><fpage>3473</fpage><lpage>3481</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1210136</pub-id><pub-id pub-id-type="pmid">17146434</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedford</surname><given-names>JS</given-names></name><name><surname>Mitchell</surname><given-names>JB</given-names></name></person-group><article-title>Dose-rate effects in synchronous mammalian cells in culture</article-title><source>Radiat. Res.</source><year>1973</year><volume>54</volume><fpage>316</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.2307/3573709</pub-id><pub-id pub-id-type="pmid">4735769</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>R&#x000fc;hm</surname><given-names>W</given-names></name><etal/></person-group><article-title>Dose-rate effects in radiation biology and radiation protection</article-title><source>Ann ICRP</source><year>2016</year><volume>45</volume><issue>Suppl 1</issue><fpage>262</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.1177/0146645316629336</pub-id><pub-id pub-id-type="pmid">26960819</pub-id></element-citation></ref></ref-list></back></article>